Standard Deviation of normal interbeat intervals as a risk marker in patients with left ventricular systolic dysfunction: A meta-analysis

International Journal of Cardiology

Volumn 141, Issue 3, 2010, Pages 313-316

  de Sousa, Marcos R ^a   Barbosa, Marco P T ^a   Lombardi, Federico ^b   Ribeiro, Antonio L P ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Heart failure; Heart rate variability; Left; Prognosis; Ventricular Dysfunction

Indexed keywords

ARTICLE; EFFECT SIZE; ELECTROCARDIOGRAPHY; GENETIC HETEROGENEITY; HEART BEAT; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE VARIABILITY; HOLTER MONITORING; HUMAN; MEDICAL RESEARCH; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; SYSTOLIC DYSFUNCTION;

DATA INTERPRETATION, STATISTICAL; HEART FAILURE; HEART RATE; HUMANS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77952880578     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.11.128     Document Type: Article

References (30)

1. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 17 3 (Mar 1996) 354-381
2. Sandercock G.R., and Brodie D.A. The role of heart rate variability in prognosis for different modes of death in chronic heart failure. Pacing Clin Electrophysiol 29 8 (Aug 2006) 892-904
3. Wilczynski N.L., and Haynes R.B. Developing optimal search strategies for detecting clinically sound prognostic studies in MEDLINE: an analytic survey. BMC Med 2 (Jun 9 2004) 23
4. Binder T., Frey B., Porenta G., et al. Prognostic value of heart rate variability in patients awaiting cardiac transplantation. Pacing Clin Electrophysiol 15 11 Pt 2 (Nov 1992) 2215-2220
5. Ponikowski P., Anker S.D., Chua T.P., et al. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 79 12 (Jun 15 1997) 1645-1650
6. Yi G., Goldman J.H., Keeling P.J., Reardon M., McKenna W.J., and Malik M. Heart rate variability in idiopathic dilated cardiomyopathy: relation to disease severity and prognosis. Heart (British Cardiac Society) 77 2 (Feb 1997) 108-114
7. Nolan J., Batin P.D., Andrews R., et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation 98 15 (Oct 13 1998) 1510-1516
8. Bonaduce D., Petretta M., Marciano F., et al. Independent and incremental prognostic value of heart rate variability in patients with chronic heart failure. Am Heart J 138 2 Pt 1 (Aug 1999) 273-284
9. Lanza G.A., Bendini M.G., Intini A., et al. Prognostic role of heart rate variability in patients with idiopathic dilated cardiomyopathy. Ital Heart J 1 1 (Jan 2000) 56-63
10. Boveda S., Galinier M., Pathak A., et al. Prognostic value of heart rate variability in time domain analysis in congestive heart failure. J Interv Card Electrophysiol 5 2 (Jun 2001) 181-187
11. Makikallio T.H., Huikuri H.V., Hintze U., et al. Fractal analysis and time- and frequency-domain measures of heart rate variability as predictors of mortality in patients with heart failure. Am J Cardiol. 87 2 (Jan 15 2001) 178-182
12. Koyama J., Watanabe J., Yamada A., et al. Evaluation of heart-rate turbulence as a new prognostic marker in patients with chronic heart failure. Circ J 66 10 (Oct 2002) 902-907
13. Kruger C., Lahm T., Zugck C., et al. Heart rate variability enhances the prognostic value of established parameters in patients with congestive heart failure. Zeitschrift fur Kardiologie 91 12 (Dec 2002) 1003-1012
14. Grimm W., Christ M., Bach J., Muller H.H., and Maisch B. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study. Circulation 108 23 (Dec 9 2003) 2883-2891
15. Karcz M., Chojnowska L., Zareba W., and Ruzyllo W. Prognostic significance of heart rate variability in dilated cardiomyopathy. Int J Cardiol 87 1 (Jan 2003) 75-81
16. Yamada T., Shimonagata T., Fukunami M., et al. Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: a prospective study. J Am Coll Cardiol 41 2 (Jan 15 2003) 231-238
17. Anastasiou-Nana M.I., Terrovitis J.V., Athanasoulis T., et al. Prognostic value of iodine-123-metaiodobenzylguanidine myocardial uptake and heart rate variability in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 96 3 (Aug 1 2005) 427-431
18. Fauchier L., Douglas J., Babuty D., Cosnay P., and Fauchier J.P. QT dispersion in nonischemic dilated cardiomyopathy. A long-term evaluation. Eur J Heart Fail 7 2 (Mar 2 2005) 277-282
19. Folino A.F., Tokajuk B., Porta A., Romano S., Cerutti S., and Volta S.D. Autonomic modulation and clinical outcome in patients with chronic heart failure. Int J Cardiol 100 2 (Apr 20 2005) 247-251
20. Brouwer J., van Veldhuisen D.J., Man in 't Veld A.J., et al. Prognostic value of heart rate variability during long-term follow-up in patients with mild to moderate heart failure. The Dutch Ibopamine Multicenter Trial Study Group. J Am Coll Cardiol 28 5 (Nov 1 1996) 1183-1189
21. Guzzetti S., La Rovere M.T., Pinna G.D., et al. Different spectral components of 24 h heart rate variability are related to different modes of death in chronic heart failure. Eur Heart J 26 4 (Feb 2005) 357-362
22. Bilchick K.C., Fetics B., Djoukeng R., et al. Prognostic value of heart rate variability in chronic congestive heart failure (Veterans Affairs' Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure). Am J Cardiol 90 1 (Jul 1 2002) 24-28
23. Szabo B.M., van Veldhuisen D.J., van der Veer N., Brouwer J., De Graeff P.A., and Crijns H.J. Prognostic value of heart rate variability in chronic congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol 79 7 (Apr 1 1997) 978-980
24. Rashba E.J., Estes M., Wang P., et al. Preserved heart rate variability identifies low-risk patients with nonischemic dilated cardiomyopathy: results from the DEFINITE trial. Heart Rhythm 3 (2006) 281-286
25. Aronson D., Mittleman M.A., and Burger A.J. Measures of heart period variability as predictors of mortality in hospitalized patients with decompensated congestive heart failure. Am J Cardiol 93 1 (Jan 1 2004) 59-63
26. Truebner S., Cygankiewicz I., Schroeder R., Baumert M., Vallverdu M., Caminal P., et al. Compression entropy contributes to risk stratification in patients with cardiomyopathy. Biomedizinische Technik 51 2 (2006) 77-82
27. Baker R.L., and Koelling T.M. Prognostic value of ambulatory electrocardiography monitoring in patients with dilated cardiomyopathy. J Electrocardiol 38 (2005) 64-68
28. Madsen B.K., Rasmussen V., and Hansen J.F. Predictors of sudden death and death from pump failure in congestive heart failure are different. Analysis of 24 h Holter monitoring, clinical variables, blood chemistry, exercise test and radionuclide angiography. Int J Cardiol 58 (1997) 151-162
29. Rashba E.J., Estes M., Wang P., et al., Investigators. Preserved heart rate variability identifies low-risk patients with nonischemic dilated cardiomyopathy: results from the DEFINITE trial. Heart Rhythm 3 (2006) 281-286
30. Coats AJ. Ethical authorship and publishing. Int J Cardiol 2009;131:149-50.